Given the current underperformance of European banks and the downsizing of IBDs (e.g. DB, Barclays), how is advisory (M&A and equity/ debt underwriting) going to develop in the future?
Are independent advisors taking over?
(This applies in particular to European banks)
| +161 | As Lehman people reconvene at UBS, Barclays needs to hire (2023) | 23 | 1d |
| +149 | Worlds Worst MDs Competition (2026 Edition) | 20 | 7h |
| +136 | Is pay at BofA really that bad? | 65 | 3h |
| +90 | Day at Macquarie | 12 | 2d |
| +89 | Lindsay Clancy - Thoughts from A2 | 21 | 2h |
| +67 | Who Killed Wall Street | 25 | 2h |
| +51 | How bad did I mess up | 10 | 2d |
| +35 | Misrepresented Houston IB | 14 | 2d |
| +33 | EB (EVR/CVP/LAZ) vs MBB (Bain/BCG) | 13 | 3h |
| +29 | No BB RO 2026 | 10 | 4d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Personally I think industry wise I think definitely EBs (+ european boutiques like Robey Warshaw) + US BB will take over more market share that DB/UBS lose.
Not sure how specific firms will do but if I had to guess DB will always have a presence (german pride + solid historic performance) in EMEA especially with European lev fin although with the piss poor balance sheet I think it'll take at least 2-3 more years of restructuring before they think about any growth. CS is still a strong player in IB esp EMEA and the CEO just said they won't be downsizing anymore (albeit I believe he was referring to S&T more so). I think Barclays wants to continue its investment into IB and grow the group, have seen couple of hires within Chemicals/Industrials/HC in the US so I'd reckon they'd be continuing that for Europe (not sure which groups in particular though just making a guess). UBS I have no idea with all the focus on PWM/AM I'm surprised they're still decently strong with IB.
I think couple 3rd tier firms like BNP/Soc Gen/HSBC will be interesting. I think in the next couple of years some will completely be even more irrelevant (Soc Gen) whereas others (HSBC) have a chance maybe to gain a bit more market share.
Just my opinion based on what I'm hearing from buddies of mine in different firms and reading the news. Then again based in the US so I could be 100% wrong.
Laudantium molestias voluptas aut at qui. Non voluptatem non occaecati consequuntur nesciunt corporis. Voluptatem aut quas praesentium expedita.
Rerum accusamus aspernatur omnis aut soluta fugiat et possimus. Odio commodi assumenda tempora vero similique ex dignissimos. Repellendus et possimus est. Maxime molestias hic tempore totam. Iure nam quia maiores quibusdam vero est.
Veritatis ut veniam cupiditate quidem distinctio. Nulla eius deserunt dolorum animi cumque vel. Odio excepturi ad ut. Delectus rerum quia eveniet quasi ut ut.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...